Additionally, low-income neighborhoods, which are disproportionately home to Black and Hispanic populations, often lack the healthcare infrastructure and pharmacy access necessary to obtain these medications
Meanwhile, research on the mechanism and efficacy of GLP-1R/GIPR dual agonists and GLP-1R/GIPR/GCGR triple agonists paves the way to a ground-breaking therapy specific for obesity, which suggests multi-target drugs may have more advantages than a single target
Tirzepatide Tirzepatide is a dual GIP and GLP-1 receptor compound designed to enhance glucose control and promote fat loss
Shima Hadidchi MD is dedicated to helping you find the best treatment plan that fits your individual needs
However, researchers have shown that GLP-1 receptors are present in the kidneys and there is emerging research that may eventually include the kidney into the proven sites of action
With the growing popularity of this medication, its essential to seek out clinics and specialists who offer comprehensive, physician-supervised programs